Position
Fidelity in Edgewise Therapeutics, Inc.
Back to the book · All holders of EWTX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $9.29M$31.50 → $40.63
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 693K | $17.2M | — | — | — | 0.0% |
| Q1 2026 | 1.02M | $32M | $31.50 | $4.63M | $10.2M | 0.0% |
| Q2 2026 | 5.49M | $223M | $40.63 | $9.29M | $181.7M | 0.0% |